Citations

Showing 10 of 108104 citations.

Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus
Gami, Apoor S., Smith, Steven A.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 142 | Issue: 2 | Pages: 29

10.7326/acpjc-2005-142-2-029 | PMID 15739976 Get It

Review: Prompt endoscopy is not a cost-effective strategy for initial management of dyspepsia
Talley, Nicholas J.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 143 | Issue: 3 | Pages: 76

10.7326/acpjc-2005-143-3-076 | PMID 16262233 Get It

Review: α-Glucosidase inhibitors improve glycemic control but have uncertain effects on patient-important outcomes in type 2 diabetes
Isley, William L.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 143 | Issue: 3 | Pages: 66

10.7326/acpjc-2005-143-3-066 | PMID 16262223 Get It

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants
Lowry, Kathryn P. , Geuzinge, H. Amarens , Stout, Natasha K. , Alagöz, Oğuzhan , Hampton, John M. , Koning, Harry J. de , Miglioretti, Diana L. , Ravesteyn, Nicolien T. van , Sprague, Brian L. , Tosteson, Anna N.A. , Weaver, Donald L. , Yaffe, Martin J. , Mandelblatt, Jeanne S. , Kurian, Allison W. , Auer, Paul L. , Berstein, Leslie, Carter, Brian D., Gaudet, Mia M. , Haiman, Christopher, Jacobs, Eric J. , John, Esther M. , Lindström, Sara , Martínez, Elena, Patel, Alpa V. , Reid, Sonya , Taylor, Jack A. , Teras, Lauren R., Vachon, Celine M. , Yao, Song, Ziogas, Argyrios, Goldgar, David E. , Chen, Chen , Chen, C , Miglioretti, Diana L , John, Esther M , Taylor, Jack A , de Koning, Harry J , Kurian, Allison W , Kerlikowske, Karla , Schechter, Clyde B. , Trentham‐Dietz, Amy , Yeh, Jennifer M. , Couch, Fergus J. , Hu, Chunling , Kraft, Peter , Polley, Eric C. , Robson, Mark E. , Hart, Steven N. , Nathanson, Katherine L. , Domchek, Susan M. , Ambrosone, Christine B. , Anton‐Culver, Hoda , Bandera, Elisa V. , Bertrand, Kimberly A. , Burnside, Elizabeth S. , Eliassen, A. Heather , Hodge, James M. , Hunter, David J. , Kooperberg, Charles , Lacey, James V. , Marchand, Loı̈c Le , Ma, Huiyan , Neuhausen, Susan L. , Newcomb, Polly A. , O’Brien, Katie M. , Olson, Janet E. , Ong, Irene M. , Pal, Tuya , Palmer, Julie R. , Rosenberg, Lynn A. , Sandler, Dale P. , Tamimi, Rulla M. , Teras, Lauren R. , Vachon, Celine M. , Weinberg, Clarice R. , Yadav, Siddhartha , Yao, Song , Weitzel, Jeffrey N.

Mayo Clinic

JAMA Oncology | February 17, 2022 | Volume: 8 | Issue: 4 | Pages: 587

10.1001/jamaoncol.2021.6204 | PMID 35175286 Get It

Endoscopic Ultrasound–Guided Dual Ultrasound Hepatic Cyst Aspiration and Sclerotherapy to Ameliorate Portal Hypertension
Levy, Michael J. , Bendel, Emily C. , Reisenauer, Christopher J., Codipilly, Don C. , Dean, Patrick G. , Gleeson, Ferga C., Kalra, Manju , Prieto, Mikel , Taner, Timuçin , Kamath, Patrick S. , Bjarnason, Haraldur , Levy, Michael J. , Amer, Hatem , Gleeson, Ferga C. , Heimbach, Julie K. , Stegall, Mark D.

Mayo Clinic

American Journal of Gastroenterology | February 17, 2022 | Volume: 117 | Issue: 5 | Pages: 715-716

10.14309/ajg.0000000000001689 | PMID 35175966 Get It

Deep brain stimulation re-imagined: An ultra-low frequency spike timing dependent plasticity-based approach for treating alcohol use disorder
Asp, Anders, Chang, Su-Youne , Asp, Anders, Boschen, Suelen L. , Luján, J. Luis

Mayo Clinic

No container title available | February 17, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1328464/v1 Get It

Abstract Alcohol use disorder (AUD) is a chronic relapsing brain disorder characterized by an impaired ability to stop or control alcohol consumption despite adverse social, occupational, or health consequences. AUD affects nearly one-third of adults at some point during their lives, with an associated cost of approximately $249 billion annually in the U.S. alone. The effects of alcohol consumption are expected to increase significantly during the COVID-19 pandemic, with alcohol sales increased by approximately 54%, potentially exacerbating health concerns and risk-taking behaviors. Unfortunately, existing pharmacological and behavioral therapies for AUD have historically been associated with poor success rates, with approximately 40% of individuals relapsing within three years of treatment. Pre-clinical studies have shown that chronic alcohol consumption leads to significant changes in synaptic function within the dorsal medial striatum (DMS), one of the brain regions associated with AUD and responsible for mediating goal-directed behavior. Specifically, chronic alcohol consumption has been associated with hyperactivity of dopamine receptor 1 (D1) medium spiny neurons (MSN) and hypoactivity of dopamine receptor 2 (D1) MSNs within the DMS. Optogenetic, chemogenetic, and transgenic approaches have demonstrated that reducing the D1/D2 MSN signaling imbalance decreases alcohol self-administration in rodent models of AUD. Here, we present an electrical stimulation approach that uses ultra-low (≤ 1Hz) frequency (ULF) spike-timing dependent plasticity (STDP) in mouse models of AUD to reduce DMS D1/D2 MSN signaling imbalances by stimulating D1-MSN afferents into the GPi and ACC glutamatergic projections to the DMS in a time-locked stimulation sequence. Our data suggest that GPi/ACC ULF-STDP selectively decreases DMS D1-MSN hyperactivity leading to reduced alcohol consumption without evoking undesired affective behaviors using electrical stimulation rather than approaches requiring genetic modification. This work represents a step towards fulfilling the unmet need for a reliable method of treating severe AUD through cell-type specific control with clinically available neuromodulation tools.
Sex Differences in Cardiac Rehabilitation Outcomes
Smith, Joshua R. , Thomas, Randal J., Bonikowske, Amanda R., Hammer, Shane M., Olson, Thomas P., Hammer, Shane M. , Smith, Joshua R , Thomas, Randal J., Bonikowske, Amanda R., Olson, Thomas P.

Mayo Clinic

Circulation Research | February 17, 2022 | Volume: 130 | Issue: 4 | Pages: 552-565

10.1161/circresaha.121.319894 | PMID 35175838 Get It

Cardiovascular disease is a leading cause of morbidity and mortality in males and females in the United States and globally. Cardiac rehabilitation (CR) is recommended by the American Heart Association/American College of Cardiology for secondary prevention for patients with cardiovascular disease. CR participation is associated with improved cardiovascular disease risk factor management, quality of life, and exercise capacity as well as reductions in hospital admissions and mortality. Despite these advantageous clinical outcomes, significant sex disparities exist in outpatient phase II CR programming. This article reviews sex differences that are present in the spectrum of care provided by outpatient phase II CR programming (ie, from referral to clinical management). We first review CR participation by detailing the sex disparities in the rates of CR referral, enrollment, and completion. In doing so, we discuss patient, health care provider, and social/environmental level barriers to CR participation with a particular emphasis on those barriers that majorly impact females. We also evaluate sex differences in the core components incorporated into CR programming (eg, patient assessment, exercise training, hypertension management). Next, we review strategies to mitigate these sex differences in CR participation with a focus on automatic CR referral, female-only CR programming, and hybrid CR. Finally, we outline knowledge gaps and areas of future research to minimize and prevent sex differences in CR programming.
A hedonic orexigenic subnetwork within the human hippocampus
Barbosa, Daniel A. N. , Gattas, Sandra , Salgado, Juliana S. , Kuijper, Fiene Marie , Leuze, Christoph , Rapp, Paul E. , Malenka, Robert C. , Miller, Kai J. , Halpern, Casey H. , Wang, Allan R. , Huang, Yuhao , Kakusa, Bina Wasunga , Luczak, Artur , Heifets, Boris Dov , Bohon, Cara , McNab, Jennifer A.

Mayo Clinic

No container title available | February 17, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1315996/v1 Get It

Abstract Only recently has the rodent hippocampus been implicated in orexigenic appetitive processing1,2. This function has been found to be mediated at least in part by lateral hypothalamic inputs involving an orexigenic neuropeptide, melanin-concentrating hormone3. This circuit remains elusive in humans. Here, we combine tractography, intracranial electrophysiology, cortico-subcortical evoked potentials, and brain-clearing 3D histology to identify an orexigenic circuit involving the lateral hypothalamus converging in a hippocampal subregion. We found that low-frequency power is modulated by sweet-fat food cues and this modulation was specific to the dorsolateral hippocampus. Lastly, structural and functional analyses of this circuit in a human cohort exhibiting dysregulated eating behavior revealed connectivity that was inversely related to body mass index. Collectively, this multimodal approach describes an orexigenic subnetwork within the human hippocampus implicated in obesity and related eating disorders.
Localized and Whole-Room Effects of Portable Air Filtration Units on Aerosol Particle Deposition and Concentration in a Classroom Environment
Kong, Meng , Li, Linhao , Eilts, Stephanie M. , Hogan, Christopher J. , Pope, Zachary , Hogan, Christopher J , Pope, Zachary C, Li, Li

Mayo Clinic

ACS ES&T Engineering | February 17, 2022 | Volume: 2 | Issue: 4 | Pages: 653-669

10.1021/acsestengg.1c00321 | PMID 37552723 Get It

Changes in diet and physical activity prevented type 2 diabetes mellitus in persons with impaired glucose tolerance
Montori, Víctor M.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 135 | Issue: 3 | Pages: 101

10.7326/acpjc-2001-135-3-101 Get It